¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Syndrome, contiguous gene"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Ayerza syndrome
    ¾Æ¿¹¸£»çÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • acquired immunodeficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº
  • acute respiratory distress syndrome
    ±Þ¼ºÈ£Èí°ï¶õÁõÈıº
  • adrenogenital syndrome
    ºÎ½Å»ý½Ä±âÁõÈıº
  • adult respiratory distress syndrome
    ¼ºÀÎÈ£Èí°ï¶õÁõÈıº
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • afferent loop syndrome
    µéâÀÚÁõÈıº
  • Albright¡¯s syndrome
    ¿Ãºê¶óÀÌÆ®ÁõÈıº
  • Alport syndrome
    ¾ËÆ÷Æ®ÁõÈıº
  • alveolar hypoventilation syndrome
    ÆóÆ÷Àúȯ±âÁõÈıº
  • abstinence syndrome
    ±Ý´ÜÁõÈıº
  • amnestic syndrome
    ±â¾ï»ó½ÇÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • aortic arch syndrome
    ´ëµ¿¸ÆÈ°ÁõÈıº
  • apallic syndrome
    ´ë³ú°ÑÁú»ó½ÇÁõÈıº
  • aqueous mis-direction syndrome
    ¹æ¼öÈ帧ÀÌ»óÁõÈıº
  • asphyctic syndrome
    Áú½ÄÁõÈıº
  • atomic bomb syndrome
    ¿øÀÚÆøÅºÁõÈıº
  • auriculotemporal syndrome
    ±Ó¹ÙÄû°üÀÚÁõÈıº
  • basal cell nevus syndrome
    ¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
  • battered child syndrome
    ¸Å¸Â´Â¾ÆÀÌÁõÈıº
  • biochemical defect syndrome
    »ýÈ­ÇÐÀû°áÇÔÁõÈıº
  • blast syndrome
    Æø¹ßÁõÈıº
  • blind loop syndrome
    (¢¡stasis syndrome) âÀÚÁ¤Ã¼ÁõÈıº
  • blind spot syndrome
    ¸ÍÁ¡ÁõÈıº
  • brain death syndrome
    ³ú»çÁõÈıº
  • branchial arch syndrome
    ¾Æ°¡¹Ì±ÁÀÌÁõÈıº
  • branchio-otorenal syndrome
    ¾Æ°¡¹Ì±ÍÄáÆÏÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Bare lymphocyte syndrome
    ¹«Ç¥Áö¸²ÇÁ±¸ÁõÈıº
  • Behcets syndrome
    º£Ã¼Æ® ÁõÈıº.
  • Behcets syndrome
    º£Ã¼Æ® ÁõÈıº
  • Benedikts syndrome
    º£³×µñÆ®ÁõÈıº
  • Blackfan-Diamond syndrome
    ºí·¢ÆÇ-´ÙÀ̾ƸóµåÁõÈıº
  • Bloom syndrome
    ºí·ç¿òÁõÈıº(¡­ñøý¦ÏØ).
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
  • CREST syndrome
    Å©·¹½ºÆ® ÁõÈıº
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Cestans syndrome
    ¼¼½ºÅºÁõÈıº.
  • Chandlers syndrome
    îµé·¯ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµåÁõÈıº.
  • Charcots syndrome
    »þ¸£ÄÚÁõÈıº.
  • Charlins syndrome
    »þ¸¦·©ÁõÈıº.
  • Chauffard-Still syndrome
    ¼îÆÄ¸£-½ºÆ¿ÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • gene translocation
    À¯ÀüÀÚÀüÀ§
  • gene, Is
    IsÀ¯ÀüÀÚ
  • gene, histocompatibility
    Á¶Á÷ÀûÇÕ¼º À¯ÀüÀÚ
  • gene, mutator
    º¯ÀÌÀ¯¹ßÀ¯ÀüÀÚ
  • gene, operator
    ÀÛµ¿À¯ÀüÀÚ
  • gene, regulatory
    Á¶ÀýÀ¯ÀüÀÚ
  • gene, repressor
    ¾ïÁ¦À¯ÀüÀÚ
  • gene, structural
    ±¸Á¶À¯ÀüÀÚ
  • gene, suppressor
    ¹ßÇö¾ïÁ¦À¯ÀüÀÚ
  • globin gene
  • gonosomal gene
    ¼º¿°»öüÀ¯ÀüÀÚ
  • histocompatibility gene
    Á¶Á÷ÀûÇÕÀ¯ÀüÀÚ.
  • histocompatibility gene
    Á¶Á÷ÀûÇÕ¼º À¯ÀüÀÚ
  • homoligous gene loci
  • human leukocyte antigen (HLA) complex gene
    »ç¶÷ ¹éÇõ±¸Ç׿øº¹ÇÕü À¯ÀüÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • lethal gene
    Ä¡»çÀ¯ÀüÀÚ(öÈÞÝë¶îîí­)
  • linked gene
    ¿¬°üÀ¯ÀüÀÚ(֤μë¶îîí­)
  • major gene
    ÁÖ À¯ÀüÀÚ(ñ«ë¶îîí­)
  • mic gene
    ¹ÍÀ¯ÀüÀÚ(ë¶îîí­)
  • mit gene
    mit À¯ÀüÀÚ(ë¶îîí­)
  • MIT gene
    MIT À¯ÀüÀÚ(ë¶îîí­)
  • modification gene
    ¼ö½ÄÈ¿¼Ò À¯ÀüÀÚ(áóãÞý£áÈë¶îîí­)
  • modifying gene
    ¼ö½ÄÀ¯ÀüÀÚ(áóãÞë¶îîí­)
  • morphogenetic gene
    ÇüÅÂÇü¼ºÀ¯ÀüÀÚ(û¡÷¾û¡à÷ë¶îîí­)
  • morphopoietic gene
    ÇüÅÂÀ¯ÀüÀÚ(û¡÷¾ë¶îîí­)
  • multiple gene
    ´ÙÀ¯ÀüÀÚ(Òýë¶îîí­)
  • mutable gene
    °¡º¯ÀÌÀ¯ÀüÀÚ(ʦܨì¶ë¶îîí­)
  • mutant gene
    º¯ÀÌÀ¯ÀüÀÚ(ܨì¶ë¶îîí­)
  • mutator gene
    º¯ÀÌÀÚ À¯ÀüÀÚ(ܨì¶í­ë¶îîí­)
  • negative gene control
    À½À¯ÀüÀÚÁ¦¾î(ëäë¶îîí­ð¤åÙ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
DMGT deoxyribonucleic acid-mediated gene transfer
FHIT fragile histidine triad [gene]
GAG glycosaminoglycan; group-specific antigen gene
gp gene product; glycoprotein; group
GTA gene transfer agent; Glanzmann thrombasthenia; glycerol teichoic acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
GP Gene products
G gene
GFP Green Fluorescent Protein gene
HSV-tk Herpes Simplex VirusThymidine Kinase gene
HERG Human Ether a-go-go Related Gene
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • battered child syndrome
    ÇÇÇÐ´ë¾Æ ÁõÈıº, ¾Æµ¿ Çдë ÁõÈıº, ¼Ò¾Æ Çдë ÁõÈıº
    ¾Æµ¿ÀÇ »À ¹× ¿¬ºÎ Á¶Á÷¿¡ ´Ù¼öÀÇ ¿Ü»ó¼º º´º¯À» ³ªÅ¸³»´Â °ÍÀ¸·Î¼­ Á¾Á¾ °æ¸·ÇÏ Ç÷Á¾À» ¼ö¹ÝÇÑ´Ù. ÀÌ·± º´º¯Àº º¸Åë ¼ºÀÎÀÇ °íÀÇÀûÀÎ °¡ÇØ¿¡ ÀÇÇØ »ý±ä´Ù. ºÎ¸ðµéÀÌ 3¼¼ ÀÌÇÏ Æ¯È÷ 1¼¼ ÀÌÇÏÀÇ À¯¾Æ¸¦ ¹«ºÐº°ÇÏ°Ô ¶§¸®°Å³ª ±âŸ ¹æ¹ýÀ¸·Î ÇдëÇÔÀ¸·Î½á ÀϾ´Â ½Åü Áõ»ó. ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç H. ÄÍÇÁ µîÀÌ ¹Ì±¹ Àü¿ª¿¡ °ÉÃÄ Á¶»çÇÏ¿´À¸¸ç, 1962³âÀÌ·¡ ¼±Áø Á¦±¹¿¡ ³Î¸® ¾Ë·ÁÁø Çö»óÀÌ´Ù. ÁÖ·Î, ¨ç ÇÇÇÏ ÃâÇ÷, Àý»ó, È­»ó µîÀÇ ÇǺΠÁõ¼¼, ¨è Àü½ÅÀÇ °ñÀý, Å»±¸, ¨é µÎ°³³» ÃâÇ÷À̳ª °æ¸·ÇÏÇ÷Á¾, ¨ê Àå±â ÆÄ¿­ ¹× ³»ÃâÇ÷ µî º¹ºÎÀÇ ¼Õ»ó, ¨ë ¼ºÀå ¹ß´Þ ÀåÇØ µîÀ» º¼ ¼ö ÀÖ´Ù. À̰ÍÀº ¿À´Ã³¯ÀÇ ¼±Áø Á¦±¹ÀÇ ±Þ¼ÓÇÑ °¡Á¤ ºØ±« Çö»ó°ú °ü·ÃÇÏ¿© ÀϾ´Â Áõ¼¼ÀÌ´Ù. ºÎºÎ°£ÀÇ °¥µîÀÌ ±Ø½ÉÇØÁö¸é À̵éÀº ¼­·Î °£ÆíÇÏ°Ô Çì¾îÁ®¾ß ÇÑ´Ù°í »ý°¢Çϰí À̶§ ¾î¸°¾ÆÀ̵éÀÌ Àå¾Ö¹°À̶ó ¹Ï°Ô µÇ¾î ¾Æ¹« ÁË ¾ø´Â ¾ÆÀ̵éÀ» ¸¶±¸ ÆøÇàÇÏ´Â µîÀÇ ÇдëÇàÀ§°¡ ³ªÅ¸³­´Ù. Çд븦 °¡ÇÏ´Â ºÎ¸ðµéÀº Á¤¼­ÀûÀ¸·Î ¹Ì¼÷ÇÑ È÷½ºÅ׸® ¼º°ÝÀÚ, ¼ºÀû ºÒ°¨Áõ, °ø°Ý¼º ¼º°ÝÀÚ, ¾ËÄÚ¿Ã Áßµ¶ÀÚ, ¸Á»óÇüÀÇ Á¤½ÅºÐ¿­Áõ ȯÀÚ µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. À̶§ Çд븦 ¹ÞÀº ¾ÆÀ̵éÀº Á¤½Å ¹ß´Þ Àå¾ÖÁõ, ¹ÝÇ×Àû ¼º°Ý, °íÁýÀÌ ¼¾ Ç×¹®±âÀû °íÂøÁõ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù. ÀÌ·¯ÇÑ Çö»óÀº Çѱ¹ÀÇ »çȸ ¹®È­¿¡¼­´Â ¾ÆÁ÷ Èñ±ÍÇÏÁö¸¸ ±Ù´ëÈ­, ÇÙ°¡Á·È­, ¿©±ÇÀÇ ½ÅÀå, ¾ËÄÚ¿Ã Àα¸ÀÇ Áõ°¡, »çȸÀû ½ºÆ®·¹½º ¿äÀÎÀÇ Áõ´ë·Î Á¡Á¡ Áõ°¡µÈ´Ù.
  • Bechet syndrome
    º£Ã¼Æ® ÁõÈıº
    º£Ã¼Æ® ÁõÈıºÀº ¹Ýº¹µÇ´Â ±¸°­ ¹× ¼º±âÀÇ ±Ë¾ç°ú ´« ¹× ÇǺΠµîÀ» ħ¹üÇÏ´Â ¿©·¯ ±â°ü¿¡ ¿À´Â ÁúȯÀÌ´Ù. ¾ÆÁ÷±îÁö È®½ÇÇÑ ¿øÀÎÀº ¸ð¸£Áö¸¸ Ç÷°ü¿°ÀÌ ÁÖµÈ º´¸® ¼Ò°ßÀ̰í ÀÚ°¡ Ç×ü°¡ 50%¿¡¼­ ÃâÇöÇÏ´Â °ÍÀ¸·Î º¸¾Æ¼­ ÀÚ°¡¸é¿ª ÁúȯÀÇ Çϳª¶ó°í »ý°¢Çϰí ÀÖ´Ù. Áõ»óÀÇ Á¤µµ´Â ½Ã°£ÀÌ °¡¸é ´úÇØÁö°í ½ÉÇÑ ÇÕº´ÁõÀÌ ¾ø´Â ÇÑ ¼ö¸í°ú´Â °ü°è°¡ ¾ø´Ù. ±×·¯³ª Ä¡·á´Â Ưº°ÇÑ °ÍÀÌ ¾ø°í ´ëÁõÀûÀÌ°í °æÇèÀûÀÎ Ä¡·á¸¦ ÇϰԵǾî Áõ»ó¿¡ µû¶ó¼­
  • Behcet's syndrome
    º£Ã¼Æ® ÁõÈıº, Behcet ÁõÈıº
    ±¸°­, ´«, ¼º±âÀÇ º´¼Ò°¡ Ư¡ÀΠƯ¹ß¼º Áúȯ. ´«¿¡¼­ º¼ ¼ö ÀÖ´Â ¼Ò°ßÀº Æ÷µµ¸·¿°, ¸Á¸·¿° ¹× °á¸·¿°À̰í, ¼º±â¿¡ ³ªÅ¸³ª´Â ¼Ò°ßÀº ´ë°³°¡ ÇÇºÎ¿Í Á¡¸·ÀÇ ±Ë¾çÀ̸ç, ±¸°­¿¡ ³ªÅ¸³ª´Â ¼Ò°ßÀº À¯»ç ¾ÆÇÁŸ¼º ±Ë¾çÀÌ´Ù. Áø´ÜÀº ÀÓ»ó ¼Ò°ß¿¡ ±Ù°ÅÇÑ´Ù. Ä¡·á¿¡´Â Àü½Å¼º ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å Åõ¿©¸¦ ÀÌ¿ë. À¯ÀüÀû ¿ä¼Ò°¡ ÀÖ´Ù°í º¸°íµÇ°í ÀÖ´Ù.
  • big heart syndrome
    °Å½É ÁõÈıº
  • black cardiac syndrome
    Èæ½ÉÀå ÁõÈıº
  • Boerhaave syndrome
    ºÆ¸£ÇϺ£ ÁõÈıº
    ±¸Åä·Î ÀÎÇØ ½ÄµµÀÇ ÀÚ¿¬ÀûÀÎ ÆÄ¿­À» ¸»Çϴµ¥ µ¿Åë°ú ¹ß¿­À» ¼ö¹ÝÇÑ °ß°©°ñ¾È ȤÀº Èä°ñÇÏ µ¿ÅëÀ» È£¼ÒÇÏ°í ¼îÅ© »óŰ¡ ¹ß»ýÇϱ⵵ ÇÑ´Ù. ±¤¹üÀ§ÇÑ ±«»ç¼º Á¾°Ýµ¿¿°Àº ÆíÃø ȤÀº ¾çÃø¼º ³óÈäÀ» ÃÊ·¡½Ã۱⵵ ÇÏ¿© 24~48½Ã°£³» »ç¸Á½Ã۱⵵ ÇÑ´Ù. ÀÓ»ó Áõ»óÀº ÈäºÎ X-¼± »çÁø»ó °æºÎ Á¶Á÷¸é°ú Á¾°Ýµ¿³» °ø±â°¡ ³ªÅ¸³ª°í Á¾°Ýµ¿ »óÀÌ È®´ëµÇ°í Á¾°Ýµ¿¿¡ ¾×¸é»ó°ú µå¹°°Ô ½É³¶°ú ÅëÇØ ½É³¶³» ¾×¸é»óÀÌ º¸À̱⵵ ÇÑ´Ù. ½Äµµ Á¶¿µ¼úµµ Áø´ÜÀÌ °¡´ÉÇÏ¸é °¡´ÉÇÑ ÇÑ ºü¸¥ Áø´Ü°ú Ä¡·á¸¸ÀÌ È¯ÀÚÀÇ »ýÁ¸À²À» ³ôÀÏ ¼ö ÀÖ´Ù.
  • bottle mouse syndrome
    ¿ìÀ¯º´ ¿ì½Ä
    Àå½Ã°£ ¿ìÀ¯¸¦ ¹°°í ÀÖ´Â À¯¾Æ¿¡ È£¹ß, ÇÏ¾Ç ÀýÄ¡¿¡´Â ¿ì½ÄÁõÀÌ ¾ø´Ù.
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • brain stem syndrome
    ³ú°£ ÁõÈıº
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
    µ¿ÀǾî=ataxia syndrome. ºê¸®ÄÉ ¿îµ¿ ½ÇÁ¶ ÁõÈıº.
  • brittle hair syndrome
    Ãë¾à ¸ð¹ß ÁõÈıº
  • bronze baby syndrome
    ûµ¿»ö ¾Æ±â ÁõÈıº
  • bruising syndrome
    Ÿ¹Ú»ó ÁõÈıº
  • burning feel syndrome
    ÀÛ¿­°¨ ÁõÈıº, ¼ÒÀÛÁ· ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
gene redundancy A situation in which many copies of the same gene exist in a genome.
(09 Oct 1997)
gene regulation The DNA and protein interactions in a gene that determine the temporal and spatial modes of expression as well as the amplitude of expression.
(14 Nov 1997)
gene regulatory protein <molecular biology> Any protein that interacts with DNA sequences of a gene and controls its transcription.
(18 Nov 1997)
gene sequencing Determination of the sequence of nucleotide bases in a strand of DNA.
(14 Nov 1997)
gene splicing A procedure by which one DNA molecule or fragment can be attached to another.
(14 Nov 1997)
gene supression <molecular biology> The halting of abnormal gene activity which results in the restoration of lost or impaired genetic function.
(09 Oct 1997)
mapping, gene Charting the positions of genes on chromosome and learning the distance, in linkage units or physical units, between genes.
(12 Dec 1998)
gene switch <molecular biology> A situation in which a cell or organism stops expressing one gene orgene group and switches to expressing a different gene or group of genes.
(09 Oct 1997)
gene synthesis <molecular biology> The complete synthesis of a gene using a DNA synthesiser (gene machine), or the assembly of oligonucleotides so synthesised into a synthetic gene, as opposed to cloning.
(14 Nov 1997)
gene targeting The integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination.
(12 Dec 1998)
gene testing Testing a sample of blood (or another fluid or tissue) for evidence of a gene. The evidence can be biochemical, chromosomal, or genetic. The aim is to learn whether a gene for a disease is present or absent.
(12 Dec 1998)
gene therapy <molecular biology> Treatment of a disease caused by malfunction of a gene, by stably transfecting the cells of the organism with the normal gene.
(18 Nov 1997)
gene transfer <molecular biology> General tem for the insertion of foreign genes into a cell or organism. Synonymous with transfection.
(18 Nov 1997)
gene translocation The movement of a gene fragment from one chromosomal location to another, which often alters or abolishes expression.
(09 Oct 1997)
receptors, calcitonin gene-related peptide Cell surface proteins that bind calcitonin gene-related peptide (cgrp) with high affinity and trigger intracellular changes which influence the behaviour of cells. Cgrp receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á